Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world

How we used our proprietary ChoiceQual conjoint technique to assess and develop a market access and pricing strategy for an influenza vaccine

How we used our proprietary ChoiceQual conjoint technique to assess and develop a market access and pricing strategy for an influenza vaccine

Our client required pricing research to better inform their pricing and access strategy for their influenza vaccine product. They wanted to understand how the attributes for Product X may or may not drive a price premium across a range of geographies and how future positioning and real world evidence availability might impact price and willingness to pay (WTP).

read more »

  • Posted by Pei Li Teh & Wan Ling Neo
  • April 16, 2020
  • Webinars

Too much choice? Cure the headaches of traditional conjoint with novel approaches

Too much choice? Cure the headaches of traditional conjoint with novel approaches

Watch this webcast in which quantitative experts Pei Li Teh and Wan Ling Neo outline some of the key limitations of traditional conjoint research and how to overcome them using novel approaches. 

read more »

  • Posted by Mariana Servin & Misti Paul
  • January 13, 2020
  • Webinars

Too much choice? Cure the headaches of traditional conjoint with novel approaches

Too much choice? Cure the headaches of traditional conjoint with novel approaches

Join us for the fourth instalment of our Innovation in #MRX webinar series in which quantitative experts Mariana Servin and Misti Paul will outline some of the key limitations of traditional conjoint research and how to overcome them.

read more »

How conjoint was used to determine the optimum features for a BGM device

Our client wanted to determine the optimal new blood glucose monitoring device – one that would best retain their current customers and also attract new ones. They also wanted to be able to rationalise the strengths of their existing portfolio against their competitors. The patient evaluation needed to reflect real life as much as possible, so that it truly reflected patient preference and could predict the future market impact of any new device. 
 
 

read more »